MARCKS participates in the activation, proliferation, chemotherapeutic resistance, and migration of CAFs, its silencing in CAFs decreases the proliferation and migration of OC cells and tumor growth, together MARCKS derived from CAFs facilitates OC metastasis (121), for which it is suggested that MARCKS could be an attractive target for the therapy of patients with OC. Here, MARCKS is linked to neoplasm.